Novartis AG said Friday that it would donate up to 130 million doses
of generic hydroxychloroquine by the end of May to support the global
response to the coronavirus pandemic.
The Swiss drug maker said hydroxychloroquine and a related drug,
chloroquine, are currently being evaluated in clinical trials for the
treatment of the virus. The company is exploring the possibility of
increasing supply to meet global demand.
Novartis said its division Sandoz, which focuses on generic
pharmaceuticals and biosimilars, holds a registration for
hydroxychloroquine in the U.S. and will therefore pursue regulatory
approval from the Food and Drug Administration and the European Medicine
Agency.
It added that it would collaborate with the World Health Organization
to determine the best distribution of the medicine on a global scale.
https://www.marketscreener.com/NOVARTIS-9364983/news/Novartis-to-Donate-Drug-in-Coronavirus-Fight-30197555/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.